OR commercialization advisory
For medtech founders and commercial leaders making consequential decisions about workflow fit, clinical adoption, launch readiness, and market entry.
Pre-call intake, a 60-minute working session, and a concise written decision brief. Independent perspective only—no promise of adoption, sales, funding, partnership, clearance, or clinical outcome.
The work is not generic
The clinical workflow has not been translated into a commercial plan.
A launch sequence is moving before the approval and stakeholder path is clear.
The field story, evidence narrative, and adoption friction do not yet agree.
Credibility, without theater
The work is informed by founder-reported operating-room experience, surgeon collaboration across specialties, commercialization leadership, and current operator responsibility—not a packaged playbook.
OR perspective
7,000+
Founder-reported spine and orthopedic cases in operating-room environments.
Operator lens
2 exits
Two startups cofounded and sold for profit; current leadership of a neuro-spine startup.
Experience also includes hospital-system approval work and surgeon adoption for a novel skin-cell point-of-care device across specialties. These backgrounds inform the questions asked; they are not endorsements or guarantees of access, performance, clearance, or outcomes.
Read the approachThe entry engagement
The OR Commercialization Diagnostic makes the decision tangible before a broader launch plan, field motion, or resource commitment is set in motion.
Focused advisory review
A focused review for medtech founders and commercial leaders deciding how an OR-facing offer fits workflow, launch planning, and market-entry risk.
$500
One-time focused advisory review
Review the live offer, confirm fit, and continue to the existing platform-hosted checkout from the Diagnostic page.
Diagnostic proof
A focused advisory review for teams preparing an operating-room launch, adoption push, or commercialization decision.
You leave with
Readiness review
Example output
Illustrative executive-readout excerpt
30-day priority
Align the launch working group around the workflow question that must be answered before field activity expands.
Friction to resolve
The current stakeholder path does not yet distinguish clinical review from facility approval requirements.
Recommended owner / action
Commercial lead: document the approval map and test the evidence and claims narrative against likely objections.
Decision gate
Do not advance the broader launch sequence until the workflow owner and approval path are defined.
The Diagnostic is strategic advisory and planning support; it does not guarantee clinical adoption, facility approval, revenue, or investment outcomes.
What happens next
The Diagnostic is designed to make the immediate decision more legible—not to substitute for regulatory, clinical, legal, investment, or market-access advice.
Complete a concise intake so the conversation starts with the decision, constraints, and work already underway.
Use the focused session to examine workflow, stakeholder alignment, launch readiness, and commercial risk together.
Receive a concise written readout of the question, critical friction, recommended owner or action, and decision gate.
A more disciplined starting point
See whether the $500 Diagnostic is the right first conversation, then move through the existing secure offer path when you are ready.
Other professional pathways remain available when they are a better fit.